CA Profile was invented for early detection of cancers and for monitoring
therapy success. It was found that elevated tumor markers could be detected
in the blood several years prior to the time when diagnosis can be made.
The Profile is not site or organ specific, however, it will detect metabolic
changes leading to or indicating cancer. HCG hormone, PHI enzyme, GGTP
enzyme, CEA, TSH, and DHEA-S are the components. The actual, super sensitive
cancer markers are HCG (sensitivity 0.3 mIU/mL), PHI and CEA. The other
three analytes are peripherally related to malignancies: GGTP monitors
the liver and biliary systems, TSH measures low or high thyroid activity,
DHEA-S is the adrenal "anti stress, pro-immunity, longevity" hormone.
(A low thyroid and/or adrenal activity predisposes to cancer.)
CA Profile was positive in 92% of established breast cancer patients,
97% of lung cancer patients, and 93% of colon cancer patients. Statistical
studies done on 571 patients with cancers of all sites resulted in 89.8%
positives. Our current statistics indicate that 68% of "healthy"
American women and 56% of "healthy" American men presnt with
elevated tumor markers.They maybe in the process of developing cancer.
Note, it may take 10 - 12 years to diagnose.s
following tumor markers are also available: PSA
(prostate), CA 15.3 (breast), CA 125 (ovary), and CA
19.9 (gastric, pancreatic).
a much broader insight into health, looking at an entire individual
rather than only cancer, the Longevity ProfileŠ was designed. This Profile
does include the Cancer Profile plus,
risk markers: homocysteine, hs-CRP, Lp(a), LDL Direct
hormones: estradiol, progesterone, free- and total testosterone
health marker: PTH
stress/death hormone: cortisol a.m. and p.m.,
hormone: IGF-1 or somatomedin,
profile: sugar, cholesterols, organ enzymes, electrolyte minerals, etc.
with differential (complete blood count): white cells, red cells, platelets,
Longevity Profile together with the Cancer Profile are like a "biochemical
fortune telling." The tests will reveal not only existing diseased conditions
but also diseases to happen in the future. As one physician put it,
"You can tell us in advance what types of diseases our patients may
develop. It is marvelous."
Schandl, M.S., Ph.D., [M.D., M.A.], FACB, SC(ASCP), CC(NRCC),